UTMD Utah Medical Products Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: UTMD

Price (delayed)

$71.55

Market cap

$227.8M

P/E Ratio

21.81

Dividend/share

$1.24

EPS

$3.28

Enterprise value

$140.47M

?
Relative Growth: Rel. Growth: 16
Relative Strength: Rel. Strength: 61
Relative Valuation: Rel. Valuation: 52
Relative Profitability: Rel. Profitability: 74

Utah Medical Products, Inc. (UTMD) is in the business of producing medical devices that are, disposable and for hospital use. The Company markets a range of medical devices used in ...

Highlights
Utah Medical Products's quick ratio has soared by 69% from the previous quarter and by 16% YoY
The debt is down by 24% YoY and by 7% QoQ
UTMD's P/E is 19% above its last 4 quarters average of 18.3 and 17% above its 5-year quarterly average of 18.7
UTMD's net income is down by 16% YoY and by 3.3% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.utahmed.com
Peers: MMSI COO TFX JNJ

Key stats

What are the main financial stats of UTMD

UTMD stock price

How has the Utah Medical Products stock price performed over time
Intraday
0.18%
1 week
0.77%
1 month
3.47%
1 year
24.46%
YTD
27.86%
QTD
3.73%

Financial performance

How have Utah Medical Products's revenue and profit performed over time
Revenue
$36.11M
Gross profit
$20.91M
Operating income
$10.27M
Net income
$10.49M
Gross margin
57.9%
Net margin
29%
The operating income has contracted by 19% YoY and by 5% from the previous quarter
UTMD's net income is down by 16% YoY and by 3.3% from the previous quarter
Utah Medical Products's operating margin has decreased by 13% YoY
The net margin is down by 10% YoY

Price vs fundamentals

How does UTMD's price correlate with its fundamentals

Growth

What is Utah Medical Products's growth rate over time

Valuation

What is Utah Medical Products stock price valuation
UTMD P/E details
P/E
21.81
P/B
1.87
P/S
6.31
EV/EBIT
10.9
EV/EBITDA
9.16
EV/Sales
3.89
UTMD's P/E is 19% above its last 4 quarters average of 18.3 and 17% above its 5-year quarterly average of 18.7
UTMD's EPS is down by 12% year-on-year and by 3% since the previous quarter
UTMD's price to book (P/B) is 19% lower than its 5-year quarterly average of 2.3 but 10% higher than its last 4 quarters average of 1.7
The equity has grown by 3.8% YoY
The stock's P/S is 19% above its last 4 quarters average of 5.3 and 9% above its 5-year quarterly average of 5.8
UTMD's revenue is down by 7% year-on-year and by 3.8% since the previous quarter

Efficiency

How efficient is Utah Medical Products business performance
UTMD's ROE is down by 17% YoY and by 4.4% from the previous quarter
Utah Medical Products's ROIC has decreased by 17% YoY and by 4.6% from the previous quarter
Utah Medical Products's return on assets has decreased by 16% YoY and by 4.5% QoQ
UTMD's ROS is down by 11% year-on-year

Dividends

What is UTMD's dividend history
Dividend details
DPS
$1.24
Dividend yield
1.73%
Payout ratio
37.7%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Utah Medical Products financials performed over time
The current ratio has soared by 70% from the previous quarter and by 16% YoY
Utah Medical Products's quick ratio has soared by 69% from the previous quarter and by 16% YoY
The debt is 100% lower than the equity
The debt is down by 24% YoY and by 7% QoQ
The equity has grown by 3.8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.